biospecimen__admin__batch_number	131.77.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	EAFA0167-E8E3-4972-BEEC-970F3F8A251A
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-BC-A216-11A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-BC-A216-11A-11
biospecimen__bio__bcr_sample_barcode	TCGA-BC-A216-11A
biospecimen__bio__biospecimen_barcode_bottom	0099052761
biospecimen__bio__day_of_creation	08
biospecimen__bio__day_of_shipment	10
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	04
biospecimen__bio__month_of_shipment	05
biospecimen__bio__plate_column	6
biospecimen__bio__plate_id	A154
biospecimen__bio__plate_row	G
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.40
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2011
biospecimen__bio__year_of_shipment	2011
biospecimen__shared__bcr_patient_barcode	TCGA-BC-A216
biospecimen__shared__patient_id	A216
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	CDD2A63A-AF46-4663-A837-39DA35EF49B2
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	3.4
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.0
clinical__chol_lihc_shared__bilirubin_upper_limit	0.6
clinical__chol_lihc_shared__creatinine_lower_level	0.5
clinical__chol_lihc_shared__creatinine_upper_limit	1.5
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.9
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	8
clinical__chol_lihc_shared__fetoprotein_outcome_value	831
clinical__chol_lihc_shared__fibrosis_ishak_score	0 - No Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__platelet_result_lower_limit	140000
clinical__chol_lihc_shared__platelet_result_upper_limit	440000
clinical__chol_lihc_shared__prothrombin_time_result_value	1.4
clinical__chol_lihc_shared__specimen_collection_method_name	Extended Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.5
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	62
clinical__clin_shared__bcr_followup_barcode	TCGA-BC-A216-F22055
clinical__clin_shared__bcr_followup_uuid	2EEFD625-0E3C-4E5A-B391-C97608CA083C
clinical__clin_shared__cancer_first_degree_relative	2
clinical__clin_shared__day_of_form_completion	23
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__followup_case_report_form_submission_reason	Scheduled Follow-up Submission
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__month_of_form_completion	7
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	211000
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2012
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2008
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	NX
clinical__shared_stage__pathologic_t	T3
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	65da8991-d9f5-4bea-b85e-5e587fe5d786
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-BC-A216-11A-11R-A154-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	11b9900d-c6ee-4f6f-a155-d737c23e1007
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.95
gdc__analytes__analyte_id	e2770fb7-dd4a-44c7-a538-a51b70b5c940
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	4bbdbe77-f3cb-4b64-9826-72debb734784
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:49:30.029218-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	3f938cba-40bb-57dd-9a8d-e502a861925c
gdc__demographic__ethnicity	not reported
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1946
gdc__diagnoses__age_at_diagnosis	22968
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-22968.0
gdc__diagnoses__days_to_last_follow_up	1351.0
gdc__diagnoses__diagnosis_id	ac512a2f-0513-5d5f-b2ea-f351dd56ae09
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iiia
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	56.142177275431294
gdc__exposures__exposure_id	4815984f-b33f-5d1c-bf5c-d53d185cfb2d
gdc__exposures__height	164.0
gdc__exposures__weight	151.0
gdc__file_id	d3f35772-03f9-46d6-ba85-db90f23cddad
gdc__file_name	86924ac9-d465-4f2b-9fdf-a93b92769fcf.mirbase21.mirnas.quantification.txt
gdc__file_size	50367
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	0fd43c29c36cdeb9612cae339d7840b1
gdc__portions__is_ffpe	false
gdc__portions__portion_id	92860296-26fd-4767-b8d3-6373be080745
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	1052
gdc__samples__initial_weight	120.0
gdc__samples__oct_embedded	false
gdc__samples__sample_id	b3ddee9b-04d5-4fa3-94c1-754bcc2a0f5d
gdc__samples__sample_type	Solid Tissue Normal
gdc__samples__sample_type_id	11
gdc__slides__percent_lymphocyte_infiltration	5.0
gdc__slides__percent_monocyte_infiltration	3.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	97.0
gdc__slides__percent_stromal_cells	3.0
gdc__slides__percent_tumor_cells	0.0
gdc__slides__percent_tumor_nuclei	0.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	4a81c1fe-c566-4a53-86eb-697d4c085815
gdc__submitter_id	mirna_swap_dr11_372_MirnaExpression6337dae8-205c-491d-8b8a-f21398cdbf57_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	BC
gdc__tissue_source_site__name	UNC
gdc__tissue_source_site__tissue_source_site_id	735fda57-1a46-5afd-a1c0-99af9115c0af
gdc__treatments__treatment_id	14b781f8-693f-5dfb-b8f8-ab36bc298115
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:08:54.287+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/65da8991-d9f5-4bea-b85e-5e587fe5d786-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/65da8991-d9f5-4bea-b85e-5e587fe5d786-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129738
manually_curated__local_md5	1a6551cba554cae60eb0f3bae1baa741
manually_curated__opengdc_download_date	2018-10-16T17:13:09.000841+02:00
manually_curated__opengdc_file_md5	8cb50fa1a03c1b4f709fa25cd2a1ebda
manually_curated__opengdc_file_size	50366
manually_curated__opengdc_id	65da8991-d9f5-4bea-b85e-5e587fe5d786-meq
manually_curated__origin_file_size	129738
manually_curated__origin_last_modified_date	Tue Oct 16 17:31:00 CEST 2018
manually_curated__origin_md5	1a6551cba554cae60eb0f3bae1baa741
manually_curated__tissue_status	normal
num	1881
